Toshi Suzuki

Dr Toshi Suzuki serves as an Honorary Research Fellow in the School of Cancer Sciences at the University of Glasgow, focusing on the molecular interplay between inflammatory diseases and cancer development. His work bridges clinical oncology and immunological research within the institution's Garscube Estate campus.

Research interests emphasize Cancer Research with specialization in Colorectal Cancer mechanisms, particularly how Inflammatory Bowel Disease progression leads to malignancy through Immunology pathways. Key investigations center on immune dysregulation biomarkers like DOCK2 and IFNγ-induced IDO1 expression.

Analysis of his 2024 Oncogene publication reveals concentrated expertise in gastrointestinal oncology and tumor immunology, demonstrating how DOCK2 deficiency exacerbates IBD-associated colorectal cancer. This work establishes critical links between immune dysfunction pathways and cancer progression within the broader disciplines of Cancer Research, Immunology, and Gastroenterology.

No scientific awards are documented in available records. Information regarding student supervision, grant funding, laboratory infrastructure, or research teams remains unspecified in current institutional profiles.